374 related articles for article (PubMed ID: 14514986)
1. The wobbler mouse: a neurodegeneration jigsaw puzzle.
Boillée S; Peschanski M; Junier MP
Mol Neurobiol; 2003 Aug; 28(1):65-106. PubMed ID: 14514986
[TBL] [Abstract][Full Text] [Related]
2. The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse.
Saberi D; Ott B; Dahlke C; Matschke V; Schmitt-John T; Theiss C
J Neuropathol Exp Neurol; 2016 Apr; 75(4):347-57. PubMed ID: 26945034
[TBL] [Abstract][Full Text] [Related]
3. [Proximal axonal injuries as experimental models for adult motoneuron degeneration].
Watabe K
Brain Nerve; 2007 Oct; 59(10):1179-86. PubMed ID: 17969359
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a manual for working with wobbler mice and criteria for discontinuation of the experiment.
Ott B; Dahlke C; Meller K; Napirei M; Schmitt-John T; Brand-Saberi B; Theiss C; Saberi D
Ann Anat; 2015 Jul; 200():118-24. PubMed ID: 25929815
[TBL] [Abstract][Full Text] [Related]
5. Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.
Fumagalli E; Bigini P; Barbera S; De Paola M; Mennini T
Exp Neurol; 2006 Mar; 198(1):114-28. PubMed ID: 16386734
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis.
Ikeda K; Iwasaki Y; Kaji R
J Neurol Sci; 2015 Jul; 354(1-2):70-4. PubMed ID: 25982504
[TBL] [Abstract][Full Text] [Related]
7. Cellular basis of steroid neuroprotection in the wobbler mouse, a genetic model of motoneuron disease.
González Deniselle MC; González SL; De Nicola AF
Cell Mol Neurobiol; 2001 Jun; 21(3):237-54. PubMed ID: 11569536
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
[TBL] [Abstract][Full Text] [Related]
9. DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.
Kok JR; Palminha NM; Dos Santos Souza C; El-Khamisy SF; Ferraiuolo L
Cell Mol Life Sci; 2021 Aug; 78(15):5707-5729. PubMed ID: 34173837
[TBL] [Abstract][Full Text] [Related]
10. Steroid Profiling in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis.
Gonzalez Deniselle MC; Liere P; Pianos A; Meyer M; Aprahamian F; Cambourg A; Di Giorgio NP; Schumacher M; De Nicola AF; Guennoun R
Endocrinology; 2016 Nov; 157(11):4446-4460. PubMed ID: 27571131
[TBL] [Abstract][Full Text] [Related]
11. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
12. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
14. Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11.
Kaupmann K; Simon-Chazottes D; Guénet JL; Jockusch H
Genomics; 1992 May; 13(1):39-43. PubMed ID: 1349581
[TBL] [Abstract][Full Text] [Related]
15. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
[TBL] [Abstract][Full Text] [Related]
16. Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis.
Bonafede R; Scambi I; Peroni D; Potrich V; Boschi F; Benati D; Bonetti B; Mariotti R
Exp Cell Res; 2016 Jan; 340(1):150-8. PubMed ID: 26708289
[TBL] [Abstract][Full Text] [Related]
17. ALS pathogenesis: recent insights from genetics and mouse models.
Swarup V; Julien JP
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):363-9. PubMed ID: 20728492
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
19. Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse).
Krieger C; Perry TL; Hansen S; Mitsumoto H; Honoré T
Can J Neurol Sci; 1992 Nov; 19(4):462-5. PubMed ID: 1423043
[TBL] [Abstract][Full Text] [Related]
20. Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.
Tovar-Y-Romo LB; Santa-Cruz LD; Tapia R
Mol Neurodegener; 2009 Jul; 4():31. PubMed ID: 19619317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
